Astera Labs (NASDAQ:ALAB) Stock Price Down 2.4% on Insider Selling

Astera Labs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Astera Labs shares fell 2.4% to $211.60 after insider sales were reported; trading volume was about 5% below its average.
  • The CEO, COO and general counsel each sold shares to cover tax withholding on vested equity awards, and retained substantial holdings.
  • Analysts’ consensus remains “Moderate Buy,” with a $320.85 average price target. The company also beat quarterly earnings and revenue estimates, with revenue up 153.6% year over year.
  • MarketBeat previews top five stocks to own in December.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s share price traded down 2.4% on Thursday following insider selling activity. The company traded as low as $211.28 and last traded at $211.60. 4,881,128 shares changed hands during mid-day trading, a decline of 5% from the average session volume of 5,135,559 shares. The stock had previously closed at $216.75.

Specifically, CEO Jitendra Mohan sold 96,089 shares of the firm's stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $206.62, for a total transaction of $19,853,909.18. Following the completion of the transaction, the chief executive officer owned 1,170,576 shares of the company's stock, valued at approximately $241,864,413.12. This trade represents a 7.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 96,089 shares of the company's stock in a transaction dated Monday, November 16th. The stock was sold at an average price of $206.62, for a total transaction of $19,853,909.18. Following the completion of the transaction, the chief operating officer owned 1,022,949 shares in the company, valued at approximately $211,361,722.38. The trade was a 8.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In related news, General Counsel Philip Mazzara sold 4,380 shares of the firm's stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $206.62, for a total transaction of $904,995.60. Following the completion of the sale, the general counsel owned 92,190 shares of the company's stock, valued at $19,048,297.80. This trade represents a 4.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Analysts Set New Price Targets

Several research firms have issued reports on ALAB. Jefferies Financial Group upped their target price on shares of Astera Labs from $270.00 to $450.00 and gave the company a "buy" rating in a research note on Wednesday, August 5th. TD Cowen decreased their price objective on shares of Astera Labs from $300.00 to $225.00 and set a "hold" rating for the company in a report on Wednesday, November 4th. Royal Bank Of Canada lowered their price objective on shares of Astera Labs from $500.00 to $400.00 and set an "outperform" rating on the stock in a research report on Wednesday, November 4th. Weiss Ratings cut shares of Astera Labs from a "buy (b-)" rating to a "hold (c)" rating in a report on Friday, October 23rd. Finally, Susquehanna dropped their target price on shares of Astera Labs from $310.00 to $258.00 and set a "neutral" rating on the stock in a report on Wednesday, November 4th. Thirteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $320.85.

Get Our Latest Analysis on ALAB

Recent Astera Labs Headlines

Here are a few of the latest headlines about ALAB:

  • Positive Sentiment: Astera Labs expanded its partnership with Hyve Solutions, integrating its Orion Compute Board, Fabric Tray and Link Board into Hyve’s Apex platform. The collaboration targets enterprise AI inference deployments and aims to shorten data-center integration time, potentially broadening demand for Astera’s connectivity systems. Article: Hyve partnership and Astera Labs
  • Positive Sentiment: Fundamentals remain a support: Astera’s latest reported quarter beat earnings and revenue estimates, with revenue up 153.6% year over year. Article: Astera Labs’ expanding role in AI connectivity
  • Neutral Sentiment: The CEO, COO, general counsel and a vice president reported share sales. The filings say the transactions covered tax withholding on vested equity awards, and the executives retained substantial holdings, making them less indicative of discretionary selling.

Astera Labs Stock Performance

The company has a market cap of $36.98 billion, a P/E ratio of 84.30 and a beta of 3.85. The firm's fifty day moving average is $288.88 and its two-hundred day moving average is $257.84.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.13. The firm had revenue of $584.90 million during the quarter, compared to analyst estimates of $550.78 million. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. The business's quarterly revenue was up 153.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.49 earnings per share. On average, equities research analysts expect that Astera Labs, Inc. will post 2.99 EPS for the current year.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently modified their holdings of ALAB. Liontrust Investment Partners LLP increased its stake in Astera Labs by 117.7% in the 3rd quarter. Liontrust Investment Partners LLP now owns 67,504 shares of the company's stock worth $24,029,000 after buying an additional 36,490 shares during the period. Zacks Investment Management bought a new position in Astera Labs in the 3rd quarter worth about $3,013,000. Kentucky Retirement Systems Insurance Trust Fund bought a new position in Astera Labs in the 3rd quarter worth about $1,389,000. Kentucky Retirement Systems bought a new position in Astera Labs in the 3rd quarter worth about $3,431,000. Finally, Algert Global LLC increased its position in shares of Astera Labs by 1,447.7% during the third quarter. Algert Global LLC now owns 9,936 shares of the company's stock worth $3,537,000 after acquiring an additional 9,294 shares during the period. 60.47% of the stock is owned by institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company's portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines